947 search results for “optimise drug design” in the Staff website
-
Yu FuFaculty of Science
y.fu@lacdr.leidenuniv.nl | 071 5276211
-
Faisal AiobiFaculty of Science
f.aiobi@lacdr.leidenuniv.nl | 071 5276788
-
Ilze BotFaculty of Science
i.bot@lacdr.leidenuniv.nl | 071 5275682
-
Suruchi BakshiFaculty of Science
s.d.bakshi@lacdr.leidenuniv.nl | 071 5272727
-
Bert WoutersFaculty of Science
b.wouters@lacdr.leidenuniv.nl | 071 5272727
-
Martijn MansonFaculty of Science
m.l.manson@lacdr.leidenuniv.nl | 071 5276805
-
Elke KrekelsFaculty of Science
e.krekels@lacdr.leidenuniv.nl | 071 5276211
-
Marije OttoFaculty of Science
m.e.otto@lacdr.leidenuniv.nl | 071 5272727
-
Jeroen BussmannFaculty of Science
j.bussmann@lacdr.leidenuniv.nl | 071 5274219
-
Bas GouloozeFaculty of Science
s.c.goulooze@lacdr.leidenuniv.nl | 071 5276329
-
Amy HarmsFaculty of Science
a.c.harms@lacdr.leidenuniv.nl | 071 5276326
-
Menno HoekstraFaculty of Science
hoekstra@lacdr.leidenuniv.nl | 071 5276582
-
Wisse van OsFaculty of Science
w.van.os@lacdr.leidenuniv.nl | 071 5272727
-
Jannik RouselFaculty of Science
j.rousel@lacdr.leidenuniv.nl | 071 5272727
-
Faisa GuledFaculty of Science
f.guled@lacdr.leidenuniv.nl | 071 5272463
-
Rongfang LiuFaculty of Science
r.liu@lacdr.leidenuniv.nl | 071 5274607
-
Rawi RamautarFaculty of Science
r.ramautar@lacdr.leidenuniv.nl | 071 5274509
-
Fouzia Lghoul-Oulad SaidFaculty of Science
f.lghoul@lacdr.leidenuniv.nl | 071 5276582
-
Anne van RongenFaculty of Science
a.van.rongen@lacdr.leidenuniv.nl | 071 5272727
-
Douwe BreimerFaculty of Science
ddbreimer@lacdr.leidenuniv.nl | 0629046596
-
Divakar BuddaFaculty of Science
d.budda@lacdr.leidenuniv.nl | 071 5276211
-
Sebastian Pomplun joins Oncode Institute to accelerate breakthroughs in cancer research
Sebastian Pomplun manages to reach proteins with drugs even where this was thought impossible. That is why he and his research group have been allowed to join Oncode Institute. With nine others, he had been selected from 72 applicants to contribute to Oncode Institute's mission: to accelerate breakthroughs…
-
Smart programming for the quantum computer that does not exist yet
Designing innovative algorithms, thinking outside the box, and brainstorming over coffee with his colleagues — this is what physicist Stefano Polla enjoys most. His success shines through in his nomination for the C.J. Kok Jury Award 2024 for PhD thesis of the Year.
-
Real-World Expensive Black-Box Optimization with Applications in Vehicle Design
PhD defence
-
Che XiaoFaculty of Science
c.xiao@cml.leidenuniv.nl | 071 5272727
-
Parto MirzaeiFaculty of Governance and Global Affairs
p.mirzaei@fgga.leidenuniv.nl | 070 8009506
-
Thomas ArblasterFaculty of Science
t.p.s.arblaster@cml.leidenuniv.nl | 071 5272727
-
Amer JaganjacICLON
a.jaganjac@iclon.leidenuniv.nl | 071 5272727
-
Eveline de BoerICLON
e.de.boer@iclon.leidenuniv.nl | 071 5271748
-
Dineke TigelaarICLON
dtigelaar@iclon.leidenuniv.nl | 071 5276552
-
Aparajita DuttaFaculty of Humanities
a.dutta@hum.leidenuniv.nl | 070 8002727
-
Lysanne PostICLON
l.s.post@iclon.leidenuniv.nl | 071 5272727
-
Design and Synthesis of Inhibitors and Probes for Sulfoquinovosidases and Xylanases
PhD defence
-
Design and Synthesis of Click Lipids as Tools to Study Immune Cell Metabolism
PhD defence
-
Design of branched swainsonines as selective Golgi alpha-mannosidase inhibitors
PhD defence
-
700,000 euros for the fight against aggressive breast cancer
To inhibit proteins that contribute to the growth of aggressive cancer cells, that’s the plan of Professor Bob van de Water and his team. They will receive over 700,000 euros from the KWF Dutch Cancer Society for their research. Researcher Maaike Vreeswijk and pathologist Danielle Cohen are affiliated…
-
Societal impact
You can apply various means to increase your societal impact: through interaction with professionals, the commercial sector or general audiences. The University can support you in this process in a number of ways.
-
€10.6 million for innovative toolboxes to tackle brain cancer
Researchers at the Universities of Amsterdam (Uva) and Leiden together with the Netherlands Cancer Institute and Oncode Institute have received a €10,6 million ERC Synergy Grant to develop innovative therapeutic approaches to target glioblastoma. This is a deadly primary brain tumour for which no curing…
-
Master student Nicole ter Laak wins third “Dr. Saal van Zwanenberg research price”
Nicole ter Laak (Master student Biopharmaceutical sciences) has won the third price of the “Dr Saal van Zwanenberg research price”. The award ceremony is on 14 November.
-
Selective cannabinoid CB2 receptor activation in Nature Communications
This March, Jara Bouma, Cas van der Horst and Laura Heitman from the Division of Drug Discovery and Safety and Laura de Paus, Richard van den Berg, Anthe Janssen and Mario van der Stelt from the LIC joined forces to determine how some drugs can specifically target the cannabinoid CB2 receptor (CB2R)…
-
Zware metalen hebben slechte reputatie, maar genezen ook kanker
Veel mensen denken dat zware metalen giftig zijn en mens en natuur altijd schade aanbrengen. Dat beeld moet genuanceerd worden, vindt hoogleraar Sylvestre Bonnet.
-
Smart monitoring of test subjects is the future of clinical research
Knowing whether or not a treatment is working just by wearing your watch? Data scientist Ahnjili ZhuParris has identified a lot of opportunities for the use of machine learning in clinical research to monitor test subjects at home.
-
‘Exposure therapy’ for bachelor students: preparing for the reality of scientific research
Already during their bachelor’s programme, students in Pharmaceutical Sciences are presented with challenging projects. One of these is the Bachelor Research Assignment (BOO in Dutch), which is often their first real experience with scientific research. This means a lot of responsibility and failures,…
-
Veni grant for ten Leiden researchers
Ten Leiden researchers have been awarded a Veni grant by the Dutch Research Council (NWO). The grant, of up to 280,000 euros, will enable them to elaborate their ideas over a period of three years.
-
Obesity and medication: when does bodyweight matter?
How can we best treat infectious diseases in people with obesity? Hospital pharmacist and PhD researcher Koen van Rhee studied how obesity affects blood levels of two commonly used medicines. He also developed a method for pharmaceutical companies to test new drugs on this patient group.
-
From lab to startup: scientist develops new treatment for nerve pain
What do you do when a discovery in the lab shows real promise? Scientist Mirjam Huizenga founded a startup to develop a new treatment for nerve pain caused by chemotherapy. ‘The goal is to give patients a better option.’
- News
-
More research on side effects: ‘Side effects are not a side issue’
We need to be quicker and better at discovering side effects. In her inaugural lecture, Agnes Kant, Professor by Special Appointment of Innovation of Pharmacovigilance, calls for more research on these adverse effects.
-
Oncode Accelerator funds preclinical development of cancer therapies
Through its Demonstrator Projects, the Dutch Oncode Accelerator consortium provides grants for preclinical cancer therapy development. The first call for these projects is open until September 2025.
-
Pharma-NL application submitted to National Growth Fund
The Ministry of Health, Welfare and Sport (VWS) submitted Pharma-NL to the R&D program of the National Growth Fund, a 20 billion euro program of the Dutch government that intends to create long-term economic growth in The Netherlands.